@article{bc5a76dcd7974ebfb812afd46c93754e,
title = "The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry",
keywords = "Eribulin, breast neoplasms, matching, genetic matching, relative effectiveness, EXPANDED ACCESS PROGRAM, EFFICACY, MESYLATE, SAFETY, CAPECITABINE, MONOTHERAPY, MULTICENTER, TOXICITY",
author = "Pouwels, {X. G. L. V.} and Geurts, {S. M. E.} and Ramaekers, {B. L. T.} and F. Erdkamp and Vriens, {B. E. P. J.} and Aaldering, {K. N. A.} and {van de Wouw}, {A. J.} and Dercksen, {M. W.} and Smilde, {T. J.} and Peters, {N. A. J. B.} and Riel, {J. M. van} and Pepels, {M. J.} and J. Heijnen-Mommers and Joore, {M. A.} and Tjan-Heijnen, {V. C. G.} and {de Boer}, M.",
year = "2020",
month = jan,
day = "2",
doi = "10.1080/0284186X.2019.1670356",
language = "English",
volume = "59",
pages = "82--89",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Routledge/Taylor & Francis Group",
number = "1",
}